Harvest Portfolios Group Inc. trimmed its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 15.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 43,306 shares of the semiconductor company’s stock after selling 8,065 shares during the period. Harvest Portfolios Group Inc.’s holdings in Synopsys were worth $21,367,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. lifted its stake in Synopsys by 20.7% in the 3rd quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock valued at $8,970,415,000 after buying an additional 3,120,401 shares in the last quarter. State Street Corp raised its holdings in shares of Synopsys by 1.2% during the second quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock valued at $3,725,362,000 after acquiring an additional 85,662 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Synopsys by 1.5% in the second quarter. Geode Capital Management LLC now owns 3,545,892 shares of the semiconductor company’s stock valued at $1,810,214,000 after acquiring an additional 51,043 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in shares of Synopsys by 29.1% in the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after acquiring an additional 585,494 shares during the last quarter. Finally, Alliancebernstein L.P. increased its position in shares of Synopsys by 10.9% during the second quarter. Alliancebernstein L.P. now owns 1,913,001 shares of the semiconductor company’s stock worth $980,757,000 after purchasing an additional 187,790 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Insider Transactions at Synopsys
In related news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Janet Lee sold 250 shares of the company’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider directly owned 11,959 shares in the company, valued at $6,338,270. The trade was a 2.05% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 4,157 shares of company stock valued at $1,945,036 over the last three months. Corporate insiders own 0.62% of the company’s stock.
Synopsys Stock Down 2.8%
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, beating analysts’ consensus estimates of $3.56 by $0.21. The firm had revenue of $2.41 billion for the quarter, compared to analysts’ expectations of $2.39 billion. Synopsys had a return on equity of 7.49% and a net margin of 13.76%.The firm’s quarterly revenue was up 65.6% on a year-over-year basis. During the same period in the prior year, the firm posted $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, equities research analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current year.
Key Synopsys News
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Q1 beat and AI-driven revenue surge — Synopsys reported Q1 revenue up ~65% and an EPS beat, driven by EDA demand and the Ansys deal; the results validate AI-led chip‑design tailwinds. Synopsys Q1 Earnings
- Positive Sentiment: Ansys integration expands long‑term TAM — Management and analysts highlight that combining EDA with Ansys simulation opens full‑system design markets (servers, autonomous systems), which could materially enlarge revenue opportunities over the medium term. Can AI Push in EDA & Ansys Integration?
- Positive Sentiment: Capital return and trader interest — Board approved a $2B buyback and there was high call‑option volume / large option trades, signaling bullish positioning by some traders. Those actions provide buy‑side support. Why Is Synopsys Stock Falling? Call Options Volume
- Neutral Sentiment: Analyst consensus still skewed positive, but stock has lagged peers — Wall Street average rating remains around “Buy” even as SNPS underperformed some tech peers over the past year, leaving room for divergence between sentiment and price action. How Is Synopsys’ Stock Performance Compared?
- Negative Sentiment: Guidance and China/export risks — Management flagged a muted near‑term quarter and a Q2 revenue guide that disappointed some investors; Reuters notes export restrictions to China as a headwind to visibility. Reuters: Muted Quarter
- Negative Sentiment: Integration costs, GAAP loss and IP weakness — Analysts and social commentary point to near‑term profitability pressure from Ansys deal costs, one‑time charges and workforce reductions, plus continued softness in the Design IP segment. QuiverQuant: Integration & IP Issues
- Negative Sentiment: Analyst price‑target trims — Several firms trimmed targets or moved to neutral/equal‑weight after the report (Piper Sandler, Wells Fargo, Rosenblatt adjustments), which can depress sentiment even if ratings remain constructive. Benzinga: Price Target Changes
Analysts Set New Price Targets
SNPS has been the topic of a number of research reports. Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. Zacks Research upgraded shares of Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Rosenblatt Securities cut their price objective on shares of Synopsys from $560.00 to $530.00 and set a “buy” rating for the company in a report on Thursday. Citigroup started coverage on Synopsys in a report on Monday, November 24th. They set a “buy” rating and a $580.00 target price on the stock. Finally, Piper Sandler dropped their price target on Synopsys from $520.00 to $430.00 and set a “neutral” rating for the company in a research report on Thursday. Eight investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Synopsys currently has an average rating of “Hold” and a consensus price target of $531.00.
Read Our Latest Research Report on SNPS
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- 3 Signs You May Want to Switch Financial Advisors
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- 1,500 Banks Just Handed the Fed Your Bank Account
- The Biggest IPO Ever… Open to Everyday Folks
- Read this or regret it forever
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
